A new publication involving BPC-157 appeared on June 1, 2026. The paper, titled "Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats," was published in the Journal of Physiology and Pharmacology, an official journal of the Polish Physiological Society.
BPC-157 remains classified as an unapproved research compound. This entry reflects only the existence and title of the publication as listed. No findings, results, or conclusions from the study are described here.
Readers interested in the background and research status of BPC-157 can consult the compound overview for further context.